Last reviewed · How we verify
NCT07325734
The Effectiveness of Guided Written Exposure Therapy for Complex PTSD in Adolescents
NA trial testing Group Guided Written Exposure Therapy for CPTSD (GWE-C) in CPTSD, Compelx Post-traumatic Stress Disorder in 130 participants. Currently enrolling.
10 October 2026
Quick facts
| Lead sponsor | Peking University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 130 |
| Start date | 10 October 2025 |
| Primary completion | 10 October 2026 |
| Estimated completion | 25 December 2026 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Group Guided Written Exposure Therapy for CPTSD (GWE-C)
- Supportive Group
Conditions studied
- CPTSD, Compelx Post-traumatic Stress Disorder — all drugs for CPTSD, Compelx Post-traumatic Stress Disorder →
Sponsor
Peking University
Who can join
Adults 10 to 18, any sex, with CPTSD, Compelx Post-traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the effectiveness of group Guided Written Exposure Therapy for Complex Post-Traumatic Stress Disorder (GWE-C) among Chinese adolescents through a randomized controlled trial. A total of 120 participants will be recruited, with 60 randomized to the GWE-C group and 60 randomized to the supportive therapy (ST) group. The GWE-C intervention will consist of 7 to 10 group sessions. The primary outcome, assessed by the International Trauma Questionnaire (ITQ), will be measured at baseline, post-treatment, 1-month follow-up, and 3-month follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07325734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group Guided Written Exposure Therapy for CPTSD (GWE-C)
Trials testing the same drug.
- NCT06931093 — The Effectiveness of Group Guided Written Exposure Therapy for CPTSD Symptoms Among Adolescents · NA · recruiting
Other recruiting trials for CPTSD, Compelx Post-traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06931093 — The Effectiveness of Group Guided Written Exposure Therapy for CPTSD Symptoms Among Adolescents · NA · recruiting
Other Peking University trials
Trials by the same sponsor.
- NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
- NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
- NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
- NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
- NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07325734 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07325734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing